Viemed Healthcare (NASDAQ:VMD) Stock Gets Price Target Trim from Freedom Broker

Viemed Healthcare (NASDAQ:VMD) had its price objective reduced by Freedom Broker from $11.00 to $10.00 in a research report sent to investors on Monday,Benzinga reports. They currently have a hold rating on the stock.

Several other brokerages also recently issued reports on VMD. Freedom Capital downgraded shares of Viemed Healthcare from a “strong-buy” rating to a “hold” rating in a report on Wednesday, August 5th. Weiss Ratings downgraded Viemed Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday, August 17th. Barrington Research assumed coverage on Viemed Healthcare in a research report on Monday, August 24th. They set an “outperform” rating and a $14.00 price target on the stock. Finally, Wall Street Zen raised Viemed Healthcare from a “buy” rating to a “strong-buy” rating in a report on Saturday, November 7th. One investment analyst has rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $12.00.

Viemed Healthcare Stock Performance

NASDAQ:VMD opened at $9.13 on Monday. Viemed Healthcare has a 12-month low of $6.18 and a 12-month high of $12.61. The company has a quick ratio of 1.16, a current ratio of 1.25 and a debt-to-equity ratio of 0.05. The firm has a market capitalization of $345.96 million, a PE ratio of 24.03, a price-to-earnings-growth ratio of 2.21 and a beta of 1.05. The firm has a 50-day moving average price of $9.27 and a 200 day moving average price of $9.62.

Viemed Healthcare (NASDAQ:VMD) last announced its quarterly earnings results on Wednesday, November 4th. The company reported $0.11 EPS for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). The business had revenue of $80.67 million for the quarter, compared to the consensus estimate of $80.78 million. Viemed Healthcare had a return on equity of 10.64% and a net margin of 5.03%. Research analysts anticipate that Viemed Healthcare will post 0.41 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Viemed Healthcare

Several large investors have recently made changes to their positions in the stock. Bank of America Corp DE bought a new stake in shares of Viemed Healthcare during the 2nd quarter worth approximately $1,810,000. Nantahala Capital Management LLC bought a new position in shares of Viemed Healthcare during the 2nd quarter worth approximately $7,209,873. Raffles Associates LP acquired a new position in shares of Viemed Healthcare during the 2nd quarter worth approximately $4,602,000. Punch & Associates Investment Management Inc. acquired a new position in shares of Viemed Healthcare during the 2nd quarter worth approximately $6,082,000. Finally, BlackRock Inc. acquired a new position in shares of Viemed Healthcare during the 2nd quarter worth approximately $54,587,000. Institutional investors own 74.24% of the company’s stock.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc. provides in-home respiratory care and related medical equipment to patients with chronic respiratory conditions. Its services are designed to help patients receive respiratory support at home rather than in a hospital or other care facility. The company supplies equipment such as non-invasive ventilators, oxygen systems and airway-clearance devices. Viemed’s respiratory therapists also help patients and caregivers use the equipment and provide ongoing clinical support. Based in the United States, Viemed serves patients in multiple states.